Anbefalt døgndose: 1 tablett tilsvarende 25 mg jern. Deklarasjon pr tablett: 25 mg jern Ingredienser: sukker, melk eller noe animalsk. Aktiv ingrediens: Ferrochel aminosyrechelatert jern (Ferrous bisglycinat). Fyllemidler: Dikalsiumfosfat, mikrokrystallinsk-cellulose Tabletthjelpestoff: Kryssbundet natriumkarboksymetylcellulose Overflatebehandlingsmiddel: Magnesiumsalter av vegetabilske fettsyrer, hydroxypropylmethylcellulose REFERANSELISTE FERROCHEL Godkjenninger: FDA 1999 US Food and Drug Administration: Agency Response Letter GRAS Notice NO. GRN 000019, 30.09.1999. JECFA 2003 Joint FAO/WHO Expert Commnittee on Food Additives: Ferrous glycinate, Report: TRS 922-JECFA 61/121 EFSA 2006 The European Food safety Authority: Ferrous bisglycinate as a source of iron for use in the manufacturing of foods and in food supplements EFSA-Q-2005-039 Studier: Allen 2000 Allen L et al. Reply to Hallberg and Hulthén. Am J Clin Nutr.2000;72(6):1593. Allen 2002 Allen LH. Advantages and Limitations of Iron Ami no Acid Chelates Iron Fortificants. Nutr. Rev. 2002;60(7):18-21. Bovell-Benjamin Bovell-Benjamin AC et al. Toddlers acceptance og whole maize meal porridge fortified with Ferrous Bisglycinate. Foods Quality and Preference. 1999;10:123-28. Bovell-Benjamin Bovell-Benjamin AC et al. Sensory Quality and Lipid Oxidation of Maize Porridge As Affected by Iron Amino Acid Chelates and EDTA. J of Food Sci ence.1999;64(2):371-76. Bovell-Benjamin Bovell-Benjamin AC et al. Iron absorption from ferrous bisglycinate and ferrous trisgly cinate in whole maize is regulated by iron status. Am J Clin Nutr.2000;71:1563-69. Coplin 1991 Coplin M et al. Tolerability of iron: A comparison of Bis-Glycinate Iron II and Ferrous Sulphate. Clinical Therapeutics.1991;13(5):606-612. Fairweahter-Tait Fairweather-Tait et al. A preliminary study of bioavailability of iron- and zinc-glycine chelates. Food Addit Contam. 1992;9(1):97-101. Fisberg 1995 Fisberg M et al. Petit Suisse cheese in the prevention of iron anemia in preschool children. Clin Pediátrica 1995;6:1924 Fisberg 1996 Fisberg M et al. The use of bread fortified with iron amino acid chelate in 4-6 year old children in Barueri, Sao Paulo. Anais-XII Congresso Latino Americano de Gastroentero logia Pediátrica e Nutricao, Brasil, Sao Paulo 1996. Abstracts 73& 1 04 Fomon 2000 Fomon FJ et al. Less than 80% of Absorbed Iron is Promptly Incorporated into Erythrocytes of Infants. J Nutr 2000;130:45-52 Fox 1998 Fox TE et al. Bioavailability og iron glycine as a fortificant in foods. Am J Clin Nutr 1998;67:664-8 Galdi 1988A Galdi M et al. Ferric glycinate iron bioavailability as deter mined by haemoglobin regeneretion. Nutr Rep Int 1988;38:591-8 Galdi 1988B Galdi M et al. Stability of Iron (III) Chelates of Nutritional Interest. J Foos Sci.1988;53(2):1844-47. Galdi 1989 Galdi M et al. J FooD Sci. Comparison of Ferric Glycinate to Ferrous Sulpfate in Model Infant Formulas: Kinetics of Vitamin Losses. J Food Sci.1989;54(6):1530-33+1539. Garcia-Casal Garcia-Casal MN et al. The effect of change in pH on the solubility of iron bis-glycinate chelate and other iron compounds. Arch latinoam Nutr.2001;51(1 suppl1):35-6. Giorgini 2001 Giorgini E et al. The use of sweet rolls fortified with iron bis-glycinate chelate in the prevention of iron deficiency anemia in preschool children. Arch Latinoam Nutr. 2001;51(1 Suppl 1) 48-53. Hallberg 2000 Hallberg L et al. No advantage of using ferrous bisglycinate as an iron fortificant. Am J Clin Nutr.2000;72(6):1592-93. Hurrell 2004 Hurrell RF et al. Enhancing the Absorption of Fortification Iron. A SUSTAIN Task Force Report. Int.J.Vitam.Nutr.Res. 2004;74(6):387-401. Iost 1998 Iost C et al. Repleting hemoglobin in iron deficiency ane mia in young children through liquid milk fortification with bioavailable iron amino acid chelate. J Am Coll Nutr 1998;17(2):187-94 Jeppsen 1993 Jeppsen RB. An assessment of long term feeding of amino acid chelates. En: The roles of amino acid chelates in animal nutrition. Ashmead (ed) Park ridge, NJ, Noyes Publications 1993. P106-113. Jeppsen 1999 Jeppsen RB et al. Safety Evaluation of Ferrous Bisglycinate Chelate. Food and Chemical Toxicology 1999;37:723-31 Jeppsen 2001 Jeppsen RB. Toxicology and safety of Ferrochel and other iron amino acid chelates. Arch Latinoam Nutr. 2001;51(Suppl 1):26-34. Klaassen 1996 Klaassen CD ed. Casarett and Doull �s Toxicology. The basic Science of poisons. 1996, 5th edn. pp.14. McGraw- Hill. New York. Langini 1988 Langini S et al. Ferric Glycinate iron bioavailability for rats. As determined by extrinsicradioisotopic labelling of infant formulas. Nutr Reports Intern 1988;38(4):729-735. Latham 2001 Latham MC et al. Micronutrient dietary support – A new fourth approach. Archivos Latinamericnos de Nutri cion.2001 march;51(1 suppl.1):37-41. Layrisse 2000 Layrisse M et al. Iron Bioavailability in Humans from Break fasts Enriched with Iron Bis-glycine Chelate, Phytates and Polyphenols. J Nutr 2000;130:2195-2199. Marchetti 2000 Marchetti M et al. Comparison of the Rates of Vitamin Degradation when Mixed with Metal Sulphates or metal Amino Acid Chelates. Journal of Food Composition and Analysis 2000;13:875-884. Miglioranza Miglioranza LH et al. Effect of long-term fortification of whey drink with ferrous bisglycinate on anemia prevalence in children and adolescents from deprived areas in Lond rina, Parana, Brazil. Nutrition,2003;19(5):419-21. Name 1995 Name JJ. Food fortification with amino acid chelated minerals. International Conference on Human Nutrition. January 21-22 1995, Salt Lake City. UT. Olivares 1997 Olivares M et al. Milk inhibits and ascorbic acid favours ferrous bis-glycine chelate bioavailability in humans. J Nutr. 1997;127:1407-1411. Osman 2002 Osman K et al. Experience with ferrous bis-glycinate chelate as an iron fortificant in milk. Int J Vitam Nutr Res. 2002;72(4):257-63. de Paula 2001 de Paula RA et al. The use of sugar fortified with iron tris- glycinate chelate in the prevention og iron deficiency ane mia in preschool children. Arch Latinoam Nutr. 2001;51(1 Suppl 1):54-59. Pineda 1994 Pineda O et al. Effectiveness of iron amino acid chelate on the treatment of iron deficiency anemia in adolescents. J Appl Nutr;46(1&2):2-13 Pineda 2001 Pineda O et al. Effectiveness of treatment of iron-defi ciency anemia in infants and young children with ferrous bis-glycinate chelate. Nutrition 2001;17(5):381-4. Pizarro 2002 Pizarro F et al. Iron bis-glycine chelate competes for the nonheme-iron absorption pathway. Am J Clin Nutr. 2002;76:577-81. Queiroz 1995 Queiroz SSQ, Torres MMA. Iron deficiency anemia: physi- opathology factors and exsperience with iron fortified milk. Pediatr Mod 1995;31:441-55 Szarfarc 2001 Szarfarc SC et al. Relative effectiveness of iron bis- glycinate chelate (Ferrochel) and ferrous sulfate in the control of iron deficiency in pregnant women. Arch Latinoam Nutr.2001 Mar;51(1 Suppl 1):42-47. Torres 1996 Torres MA et al. Fortification of fluid milk in the preven tion and treatment of infant iron deficiency anemia. Revista de Saúde Pública 1996;30:350-7 Fakta om – skånsom med Fagbrosjyre nivå II Vitalkost AS, Wirgenesvei 11, 3157 Barkåker, Telefon 33 00 38 70, Telefax 33 00 38 78, Email [email protected], www. 1999A 1999B 2000 1992 2001 2003 a aminoJern Ferrochel inneholder ikke gluten, aminojern.no maksimal effekt Milman 2013 Milman N et al. Ferrous bisglycinate vs ferrous sulphate in pregnancy. Journal of Perinatal Medicine version 2013.08.29 JPMed.2013.0153R1